Looking at the impact of COVID-19 on the economy & the MedTech industry in China

Ipsos’ Medical Devices & Diagnostics (MD&D) team in China has created a series of reports, with aim to shed some light on the questions that have arisen regarding the impact of COVID-19 on the domestic economy, healthcare industry and specifically, the medical devices sector in China.

The author(s)

  • Peter Yang Healthcare, China
  • Angie Li Country Service Line Leader, Healthcare, China
Get in touch

Read the part 3 / June 9 report:

Coronavirus: Global trends and impact on China’s healthcare industry (May 2020). Highlights include:

  • Globally, the outbreak has been gradually brought under control after peaking
  • Worried about a second wave of outbreak, China remains vigilant about COVID-19 control
  • Impact on the value of healthcare is sustained, with increasing workload on health workers, due to infection control and testing
  • Recovery of medical service in most regions in China has sped up
  • Public hospital revenue in 2020 expects flat growth, while private ones to suffer loss

Hospital volumes and consumables tracking: An Ipsos study sampled from 40 hospitals in major provinces across China. Highlights include:

  • Extent of the impact on hospital outpatient, inpatient and surgery volume
  • Year-on-year comparison of surgery volume in main departments
  • Change in volume of use of selected low- and high- value consumables

Ongoing reports will be added here, as they are released:

Part 3 June 9
Part 2 April 21
Part 1 March 25

The author(s)

  • Peter Yang Healthcare, China
  • Angie Li Country Service Line Leader, Healthcare, China

More insights about Health

Society